1. Home
  2. SYRE vs FIGS Comparison

SYRE vs FIGS Comparison

Compare SYRE & FIGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • FIGS
  • Stock Information
  • Founded
  • SYRE 2013
  • FIGS 2013
  • Country
  • SYRE United States
  • FIGS United States
  • Employees
  • SYRE N/A
  • FIGS N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • FIGS Apparel
  • Sector
  • SYRE Health Care
  • FIGS Consumer Discretionary
  • Exchange
  • SYRE Nasdaq
  • FIGS Nasdaq
  • Market Cap
  • SYRE 841.4M
  • FIGS 694.0M
  • IPO Year
  • SYRE 2016
  • FIGS 2021
  • Fundamental
  • Price
  • SYRE $14.10
  • FIGS $4.95
  • Analyst Decision
  • SYRE Buy
  • FIGS Hold
  • Analyst Count
  • SYRE 8
  • FIGS 5
  • Target Price
  • SYRE $50.00
  • FIGS $4.75
  • AVG Volume (30 Days)
  • SYRE 553.9K
  • FIGS 1.6M
  • Earning Date
  • SYRE 05-08-2025
  • FIGS 05-08-2025
  • Dividend Yield
  • SYRE N/A
  • FIGS N/A
  • EPS Growth
  • SYRE N/A
  • FIGS N/A
  • EPS
  • SYRE N/A
  • FIGS 0.01
  • Revenue
  • SYRE N/A
  • FIGS $561,166,000.00
  • Revenue This Year
  • SYRE N/A
  • FIGS $0.34
  • Revenue Next Year
  • SYRE N/A
  • FIGS $3.94
  • P/E Ratio
  • SYRE N/A
  • FIGS $700.24
  • Revenue Growth
  • SYRE N/A
  • FIGS 3.02
  • 52 Week Low
  • SYRE $10.91
  • FIGS $3.57
  • 52 Week High
  • SYRE $40.49
  • FIGS $7.06
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 48.32
  • FIGS 65.09
  • Support Level
  • SYRE $12.29
  • FIGS $4.41
  • Resistance Level
  • SYRE $15.77
  • FIGS $4.08
  • Average True Range (ATR)
  • SYRE 1.06
  • FIGS 0.25
  • MACD
  • SYRE 0.08
  • FIGS 0.14
  • Stochastic Oscillator
  • SYRE 52.08
  • FIGS 86.45

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About FIGS FIGS Inc.

FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company generates maximum revenue from United States. Sales are generated through the Company's digital platforms.

Share on Social Networks: